Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 214 of the 216 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for management of osteoporosis in men. EVIDENCE: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and evidence quality. CONSENSUS PROCESS: Consensus was guided by systematic evidence reviews, one in-person meeting, and multiple conference calls and e-mails. Task Force drafts were reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee; representatives of ASBMR, ECTS, ESE, ISCD; and members at large. At each stage, the Task Force received written comments and incorporated needed changes. The reviewed document was approved by The Endocrine Society Council before submission for peer review. CONCLUSIONS: Osteoporosis in men causes significant morbidity and mortality. We recommend testing higher risk men [aged ≥70 and men aged 50-69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry. Laboratory testing should be done to detect contributing causes. Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided. Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of -2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors. Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Laboratory testing is indicated to exclude secondary causes of osteoporosis [1, 14, 17] (Table 4).”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [17]
In the citing paper
“The Endocrine Society recommended that men with high fracture risk should receive an agent with proven antifracture activity irrespective of receiving testosterone or not (50).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [50]
Citations
Cites
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Epidemiology of adult fractures: A review
Court-Brown, C. M., & Caesar, B. (2006) · Injury · doi:10.1016/j.injury.2006.04.130 · Cited by 3,672
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citationVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 2×
“Vitamin D at high doses may result in toxicity (hypercalcemia or hypercalciuria), but this is rarely seen unless 25(OH)D levels exceed 150 ng/ml (375 nmol/liter) (121), and such levels are unlikely with the doses of vitamin D recommended here.”
Background
Research works printed but not linked: 4
- Rao, 1996, Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders, 306
- Siegel, 1995, Metabolic bone diseases and disorders of the gastrointestinal tract, 113
- Barragry, 1978, Intestinal cholecalciferol absorption in the elderly and in young subjects., Clin Sci Mol Med, 55, 213
- Finkelstein, 2008, Toward a physiologically-based definition of hypogonadism in men: dose-response relationship between testosterone and bone resorption (Abstract 1102). ASBMR 30th Annual Meeting 1001–1300., J Bone Miner Res, 23, S2
Cited by
Items 501–600 of 669
Closing the Osteoporosis Treatment Gap with Bone Health and Fracture Liaison Services
Sagalla, N., Lee, R., de Souza, T. G., & Colon-Emeric, C. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-56204-4_41 · Cited by 1
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes
Ruggiero, C., Caffarelli, C., Calsolaro, V., Tafaro, L., Riuzzi, F., Bubba, V., Napoli, N., Ferracci, M., Mecocci, P., Giusti, A., et al. (2025) · Drugs & Aging · doi:10.1007/s40266-024-01163-4 · Cited by 1
Opportunistic screening for metabolic bone disease in high energy fracture patients
Gordon, G., Johnson, B., Marquardt, O., Young, D., Beltran, M. J., & Pierrie, S. N. (2025) · Injury · doi:10.1016/j.injury.2025.112147 · Cited by 1
Osteoporosis in men: what changed?
Tomková, S., & Vrsko, M. (2019) · Clinical Osteology · doi:10.36290/clo.2019.016 · Cited by 1
Chiang-ngernthanyakun, K. (2019) · Mahidol Dental Journal · Cited by 1
The health and performance characteristics of current and retired jockeys in Ireland
Cullen, S. (2014) · Dublin City University Open Access Institutional Repository (Dublin City University) · Cited by 1
Anagnostis, P. G., Vakalopoulou, S., Karras, S. Ν., Charizopoulou, M., & Garipidou, V. (2013) · Haemophilia · doi:10.1111/hae.12284 · Cited by 1
Clinical Practice Guidelines for Osteoporosis: Translating Data to Patients?
ORWOLL, E. S. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0957 · Cited by 1
Self-citationMale osteoporosis: Recommendations to improve its treatment
Debiais, F. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105250 · Cited by 1
Ostéoporose masculine : des recommandations pour améliorer sa prise en charge
Debiais, F. (2021) · Revue du Rhumatisme · doi:10.1016/j.rhum.2021.05.009 · Cited by 1
김경희 (2019) · YUHSpace (Yonsei University Medical Library) · Cited by 1
Hayawi, L. M., Graham, I. D., Tugwell, P., & Yousef, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216196 · Cited by 1
SCREENING OF OSTEOPOROSIS IN MEN
Kirilova, E., Nikolov, N., Kirilov, N., Nikolov, M., & Владева, С. (2022) · Rheumatology (Bulgaria) · doi:10.35465/30.2.2022.pp18-27 · Cited by 1
Mody, E., Sellmeyer, D. E., Joy, E. A., Rosenflanz, T., Simon, D., Veytsman, Y., Andersen, C., Mohammad, H., Kelley, T., Batcher, B., et al. (2024) · doi:10.2196/preprints.56967 · Cited by 1
Testosterone Treatment and Fractures in Men with Hypogonadism
Kovac, E., Weiss, R. E., & Arap, W. (2024) · New England Journal of Medicine · doi:10.1056/nejmc2401934 · Cited by 1
Bone-Targeted Therapy: Rationale and Current Status
Gartrell, B. A., & Saad, F. (2014) · Current clinical urology · doi:10.1007/978-1-4939-1176-9_10
Clinical and Research Applications of Bone Mineral Density Examinations
Lenchik, L., Wuertzer, S. D., & Register, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2001-3_6
A Case of Multiple Osteoporotic Compression Fractures in Young Man with Budd-Chiari Syndrome
Kim, S. H., Yang, T. U., Choi, B. K., Yoo, H., Seo, J. A., Choi, K. M., Kim, N. H., Kim, S. G., Baik, S. H., Cho, Y., et al. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.4.334
Stuenkel, C. A., & Ettinger, B. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00065-0
OSTEOPOROSIS AS A NOVEL MARKER OF UTERINE CANCER RISK FACTOR
Al-Jawadi (2014) · American Journal of Applied Sciences · doi:10.3844/ajassp.2014.105.108
Salud del hombre mayor: más allá de la urología
B., C. E. G. (2014) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(14)70015-x
The Evidence-Based Well Male Examination in Adult Men
Flynn, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-26091-4_7
Henze, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5524
Preventing and treating osteoporosis in men
O’Connell, M. B., & Vondracek, S. F. (2013) · Pharmacy Today · doi:10.1016/s1042-0991(15)31276-7
Frequency and causes of osteoporosis among males referred for bone densitometry
Zapata, P. A., Contreras, O. Ó., & González, V. G. (2016)
Bone Loss or a Case of Mistaken Gender?
Borges, J. L. C., & Haddad, L. P. (2016) · journal of Clinical & Experimental Orthopaedics · doi:10.4172/2471-8416.100020
Li, Y., & Wu, Y. (2016) · Journal of Osteoporosis and Physical Activity · doi:10.4172/2329-9509.1000176
Anti-Osteoporotic Effect, Extra-Skeletal Benefi ts and Risks of Other Agents
Park, J. (2013) · Korean Journal of Family Practice
Vitamin D status and bone turnover markers among Han-Chinese men
Pei, Y., Lu, Y., Liu, M., Fang, F., Cheng, X., Ma, L., Zhong, W., Li, J., & Li, C. (2014) · Biomedical Research-tokyo
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Oleson, C. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-45084-1_6
Clinical Manifestation and Diagnosis of Androgen Deficiency
Święcicka, A., & Wu, F. C. W. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_23-1
Osteoporosi: una patologia di genere? Il punto di vista maschile
Greco, E. A., & Migliaccio, S. (2018) · L Endocrinologo · doi:10.1007/s40619-018-0453-0
Pasiyeshvili, L. M., & Ivanova, K. (2018) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2018-1-2-143-175-179
Titova, Y. A., MISURA, K., & Кравчун, Н. О. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.4.2018.140184
Low Bone Mass and Klinefelter Syndrome
Paul, T., Sridharan, K., & Kapoor, N. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.257242
Wainberg, S. K. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2019.tde-03122019-135146
Bone Mineral Density in Male Hospital Physicians over the Age of 65 Years
Sylvetsky, N., Shahar, C. F., Frankel, M., & Munter, G. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2003126
Improving Osteoporosis Screening Rates in a Primary Care Practice
Doreau, H. (2020) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/17385244
Testicular Function and Skeletal Alterations
Ferlin, A. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_8
Management of bone health in men with prostate cancer
Taxel, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00057-5
Who should be screened for osteoporosis?
Crandall, C. J., & Ensrud, K. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00062-9
Evaluación, indicaciones y contraindicaciones del tratamiento con testosterona en varones
Ortiz-Flores, A. E., Corrales, E. P., Castro, M. A., & Escobar-Morreale, H. F. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.10.008
Iatrogenic osteoporosis. Part III
Grygorieva, N. V. (2018) · Medicine of Ukraine · doi:10.37987/1997-9894.2018.9(225-6).200368
Poon, Y. (2018) · TSpace (University of Toronto)
Soler, I. M. (2020) · Institutional Repository of the University of Granada (University of Granada) · doi:10.30827/digibug.65406
Aplicabilidade dos guias de prática clínica ao tratamento de idosos e indivíduos com multimorbidade
de Souza, M. Q. (2019) · UNIFESP Institutional Repository (Universidade Federal de São Paulo)
Yousef, F. K. (2015) · Assiut Scientific Nursing Journal · doi:10.21608/asnj.2015.192268
Osteoporotic Hip Fractures in the Elderly: Is there a Gender Difference?Preprint
Wan, S. A., Tiong, I. K., Chuah, S. L., Cheong, Y. K., Singh, B. S. M., Lee, K. H., Lee, W. W. H., Teh, C. L., Tiong, J. K., Samsudin, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-902613/v1
Thakkar, R., Rajshekhar, S., & Dwivedi, S. (2021) · National Journal of Clinical Orthopaedics · doi:10.33545/orthor.2021.v5.i1b.264
Secondary Causes and Contributors to Osteoporosis
Ryan, L. E., & Ing, S. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-83951-2_5
Osteoporosis in patients with coronary artery disease after coronary bypas surgery
Коков, А. Н., Masenko, V. L., Кашталап, В. В., Hryachkova, O. N., Семенов, С. Е., & Барбараш, О. Л. (2021) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2021-10-4-17-28
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_25
Osteoporosis Management: Gaps in Patients’ Care and Treatment
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_21
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Anawalt, B. D. (2022) · doi:10.1093/med/9780198870197.003.0482
Valencia, W. M., & Florez, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-76271-1_20
Osteoporotic Hip Fractures in the Elderly: Is There a Gender Difference?Preprint
Wan, S. A., Tiong, I. K., Chuah, S. L., Cheong, Y. K., Singh, B. S. M., Lee, K. H., Lee, W. W. H., Teh, C. L., Tiong, J. K., Samsudin, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-902613/v2
Manchireddy, B., Marte, M. G. N., & Adler, R. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-83951-2_7
Self-citationOstroff, M. L., & Costantino, R. C. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.osteo_overview
Zajac, J. D., Seeman, E., Russell, N., Ramchand, S. K., Bretherton, I., Grossmann, M., & Davey, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11263-2
Hypogonadism and Testosterone Therapy in Elderly Men
Yeap, B. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66168-8
(2018) · Andrology · doi:10.1111/andr.12539
Torres, M. M., Martín, A. G., Bolívar, V. C., & Sevilla, J. E. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.06.011
Kurşun Endüstrisi Çalışanlarında Osteoporoz Riski: Olgu Sunumu
Hasanlı, Y. S. (2022) · Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi · doi:10.18614/deutip.1174686
Pharmacotherapy of osteoporosis in males
Knyazkova, І. І., Kuzmіnova, N. V., Osovska, N. Y., & Bogun, M. V. (2016) · Likarska sprava · doi:10.31640/ls-2016(3-4)16
Polymorphism of LRP4 Gene (rs9667108) among Post Menopause Women with Osteoporosis
Kavoosian, S., Asgharian, A. M., Asouri, M., Fattahi, S., Amirbozorgi, G., Kheirandish, A., Abolfazli, S., Lotfi, M., Ebrahimi, N., & Ataee, R. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i4.12457
Pharmacological Treatment of Osteoporosis in Older Patients
Dejaeger, M., Dupont, J., Laurent, M. R., & Gielen, E. (2023) · Practical issues in geriatrics · doi:10.1007/978-3-031-28061-0_21
Osteoporoza pri moških – pomen hipogonadizma
Antonič, K. G., & Kocjan, T. (2023) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3435
The use of medium-chain triglycerides in patients with cystic fibrosis
Zarubina, V., Высоколова, О. В., Mukhina, M. A., Yakushina, Е. E., & Kekeeva, T. N. (2024) · Лечащий врач · doi:10.51793/os.2024.27.3.016
Hamdy, R. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99550-4.00008-3
Zoledronic acid—Annual infusions
Hamdy, R. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99550-4.00011-3
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258782
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258776
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258785
Zhu, B., Hu, S., Guo, J., Dong, Z., Dong, Y., & Li, F. (2023) · Figshare · doi:10.6084/m9.figshare.23258788
Salman, R. I., Salih, K. M., & Al-Rahal, N. K. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.829472
Persistent Flu-Like Symptoms in a Patient With Glaucoma and Osteoporosis
Bodnar, T. W. (2024) · Federal Practitioner · doi:10.12788/fp.0477
Role of estrogens and androgens in osteoporosis
Laurent, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00041-8
Hypogonadism and testosterone therapy in elderly men
Yeap, B. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00046-7
Osteoporosis in males and its causative factors in Damascus HospitalPreprint
IbraheemTalib, A., Al-Doori, I. A., & Hamoud, T. (2024) · Research Square · doi:10.21203/rs.3.rs-5006969/v1
RETROSPECTIVE ANALYSIS OF OSTEOPOROTIC VERTEBRAL FRACTURES
Şenoymak, M. C. (2024) · Ahi Evran Medical Journal · doi:10.46332/aemj.1468364
Meslek Hastalıkları Epidemiyolojisi ve Çalışan Sağlığında Sürdürülebilirlik
Keleş, E., GULER, B. D., Çalmaz, A., Özkınalı, S., Comba, A., & Çiçek, G. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3481
Improving High-Risk Osteoporosis Medication Adherence and Safety With an Automated Dashboard
Tran, D., Narla, R. R., Wojtowicz, M., Spoutz, P. M., & Wysham, K. D. (2025) · Federal Practitioner · doi:10.12788/fp.0551
Leeyaphan, J., Rojjananukulpong, K., Intarasompun, P., & Peerakul, Y. (2025) · Cureus · doi:10.7759/cureus.79789
Could PTH/Ca Ratio Serve as a New Marker for Evaluating Bone Metabolism in Hemophilia Patients?
Ersal, T., Hunutlu, F. Ç., Gürsoy, V., Elgün, E., Yavuz, Ş., Akkuş, İ. D., Baş, İ., Özkocaman, V., & Özkalemkaş, F. (2025) · Diagnostics · doi:10.3390/diagnostics15050638
Liu, Y., Ge, Y., Shi, M., Zhang, L., Chen, L., & Xia, W. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08473-7
Raeini, A. G., Hoveidaei, A. H., Zarepour, F., Taghavi, S. P., Shirinezhad, A., Azarboo, A., Hamrahian, A. H., & Conway, J. D. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07418-z
Muzzammil, M., Minhas, M. O., & Jamil, A. (2025) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2025.103018
Management of Osteoporosis in the Orthopedic Trauma Patient
Chou, S. H.-H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80825-8_8
Vincentis, S. D., David, K., Antonio, L., & Rochira, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_22
Inquadramento diagnostico-terapeutico dell’osteoporosi maschile
Berton, A. M., Sagone, N., Massimo, P., & Barale, M. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01689-8
Mokrzycka, A., Żuczek, A., Dyndał, K., Broda, M., Żuczek, O., Urbańska, K., Szczap, I., Hawryluk, A., & Marzec, K. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3893
Features of zoledronic acid use in the treatment of osteoporosis in elderly patients
Dudinskaya, Е. N. (2025) · Russian Journal of Geriatric Medicine · doi:10.37586/2686-8636-3-2025-343-350
Maximal Strength is a Strong Determinant of Hip Geometry Indices in a Group of Older Sarcopenic Men
Maliha, E., Khalil, N., Pinti, A., & Hage, R. E. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-08455-2_25
Khatri, K., Gupta, N., Aggarwal, S., Lakhani, A., Dahuja, A., Kankaria, A., & Kanwal, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29025-1.00017-5
Precocious Idiopathic Primary Osteoporosis in Men: A Case Report
Pereira, P. (2025) · Gazeta Médica · doi:10.29315/gm.850
Metadata
- Authors
- Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S.
- Affiliations
- Mercy Health (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Oregon Health & Science University (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- 1802-1822
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2075195284
- Cited by
- 611
- References
- 216
- Citations by year
- 2026: 38 · 2025: 42 · 2024: 32 · 2023: 46 · 2022: 53 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 48 · 2017: 39 · 2016: 42 · 2015: 31 · 2014: 50 · 2013: 51 · 2012: 11
- FWCI
- 48.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- male osteoporosis, osteoporosis management, fracture risk assessment, dual-energy X-ray absorptiometry, bone mineral density, calcium and vitamin D supplementation, weight-bearing exercise, smoking, alcohol consumption, T-score, osteopenia, older men
- MeSH terms
- Aged, Endocrinology, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.